4
Changes in Ownership
ImmunityBio, Inc. Filed Acc 0001647994-26-000004
Director sold 175,000 shares at an average $10.19 ($1,783,602)
- Director gave up 6,026 shares (to pay taxes)
- Director acquired 15,243 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Simon Barry J. · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-20 | Sale : show line 1 in the form 10b5-1 | −10,000 | $9.25 | $92,500 | 3,081,604 | D |
| 2026-02-22 | Exercise or conversion : show line 2 in the form 10b5-1 | +15,243 | 3,096,847 | D | ||
| 2026-02-22 | Shares withheld for taxes : show line 3 in the form 10b5-1 | −6,026 | $8.70 | $52,426 | 3,090,821 | D |
| 2026-02-23 | Sale : show line 4 in the form 10b5-1 | −165,000 | $10.25 | $1,691,102 | 2,925,821 | D |
| Open-market sales · 175,000 sh · avg $10.19 · $1,783,602 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-22 | Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Units | −15,243 | 15,245 | D |
Loading xslF345X05/wk-form4_1771981423.xml…